Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in...
Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme ...
Global Net Revenue of $73.1 Million for the First Quarter of 2026, Up 7% Over the Prior Year and Against the Highest Growth Quarter of 2025 GAAP Operating...
Barchart Research What to Expect from EOLS Earnings EOLS Generated May 1, 2026 Current Price $5.33 EPS Estimate $$-0.22 Consensus Rating Moderate Buy Average Move 14.25% Can Evolus Convince Anyone the...
Barchart Research What to Expect from EOLS Earnings EOLS Generated May 1, 2026 Current Price $5.33 EPS Estimate $$-0.22 Consensus Rating Moderate Buy Average Move 14.25% Can Evolus Convince Anyone the...
Barchart Research What to Expect from EOLS Earnings EOLS Generated May 1, 2026 Current Price $5.33 EPS Estimate $$-0.22 Consensus Rating Moderate Buy Average Move 14.25% Can Evolus Convince Anyone the...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2026 financial...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in...
Evolus, Inc. (NASDAQ: EOLS) a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during March 2026 of an aggregate of 85,516 restricted...
Total Net Revenue of $90.3 Million for the Fourth Quarter and $297.2 Million for the Full-Year 2025, Representing Growth of 14% and 12% Over the Prior Year ...